Inhibitors | Comment | Organism | Structure |
---|---|---|---|
adenosine dialdehyde | irreversible inhibitor | Mus musculus | |
DZ2002 | reversible inhibitor | Mus musculus |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
S-adenosyl-L-homocysteine + H2O | Mus musculus | - |
L-homocysteine + adenosine | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mus musculus | P50247 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
S-adenosyl-L-homocysteine + H2O | - |
Mus musculus | L-homocysteine + adenosine | - |
? |
Synonyms | Comment | Organism |
---|---|---|
S-adenosyl-L-homocysteine hydrolase | - |
Mus musculus |
SAHH | - |
Mus musculus |
General Information | Comment | Organism |
---|---|---|
drug target | adenosylhomocysteinase inhibitors are promising complementary therapeutic agents in organ transplantation. Inhibitors (AdOx and DZ2002) alleviate allograft rejection in cardiac transplantation by inhibition of CD4+ T alloimmune response | Mus musculus |